These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12154491)

  • 41. A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.
    Elewski BE; Kircik LH; Stasko N; De Leon E; Enloe C; Durham T; Maeda-Chubachi T
    J Drugs Dermatol; 2018 Aug; 17(8):888-893. PubMed ID: 30124729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are placebo-controlled trials of creams for athlete's foot still justified?
    Crawford F; Harris R; Williams HC
    Br J Dermatol; 2008 Sep; 159(4):773-9. PubMed ID: 18834482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 44. Common fungal infections of the feet in patients with diabetes mellitus.
    Tan JS; Joseph WS
    Drugs Aging; 2004; 21(2):101-12. PubMed ID: 14960127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis.
    Smith EB
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S24-S28. PubMed ID: 8496408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ciclopirox gel in the treatment of patients with interdigital tinea pedis.
    Aly R; Fisher G; Katz I; Levine N; Lookingbill DP; Lowe N; Menter A; Morman M; Pariser DM; Roth HL; Savin RC; Shavin JS; Stewart D; Taylor JR; Tucker S; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():29-35. PubMed ID: 14567368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
    Med Lett Drugs Ther; 2004 Jun; 46(1185):50-1. PubMed ID: 15211288
    [No Abstract]   [Full Text] [Related]  

  • 48. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of antifungal constituents from the Miao medicinal plant Isodon flavidus.
    Li JX; Li QJ; Guan YF; Song X; Liu YH; Zhang JJ; Li WF; Du J; Zhu M; Banas JA; Li XN; Pan LT; Zhang HJ
    J Ethnopharmacol; 2016 Sep; 191():372-378. PubMed ID: 27340103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cutaneous toxicity of dihydroxydichlordiphenylmethane, a new fungicide for athlete's foot.
    GAUL LE; UNDERWOOD GB
    J Indiana State Med Assoc; 1949 Jan; 42(1):22-4. PubMed ID: 18122006
    [No Abstract]   [Full Text] [Related]  

  • 52. The rationale of athlete's foot.
    PASTERNACK AB
    J Natl Assoc Chirop; 1946 Feb; 36(2):11-9. PubMed ID: 21014450
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M
    Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antimycotic therapy of Tinea pedis and other foot mycoses].
    Stock I
    Med Monatsschr Pharm; 2008 Jul; 31(7):247-56; quiz 257-8. PubMed ID: 18808073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholesterol, cancer, and rebooting a treatment for athlete's foot.
    Chua NK; Coates HW; Brown AJ
    Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Syphilis as Athlete's Foot: "The Great Imitator" Strikes Again.
    Boctor N; Aronowitz P
    J Gen Intern Med; 2020 Jan; 35(1):350. PubMed ID: 31705478
    [No Abstract]   [Full Text] [Related]  

  • 57. A novel two-step kit for topical treatment of tinea pedis--an open study.
    Shemer A; Grunwald MH; Davidovici B; Nathansohn N; Amichai B
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1099-101. PubMed ID: 20136678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Borotannic complex in athlete's foot.
    Simmonds AJ
    Practitioner; 1971 Feb; 206(232):265-70. PubMed ID: 4928968
    [No Abstract]   [Full Text] [Related]  

  • 59. Tinea and Onychomycosis.
    Rosen T
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot.
    Auger P; Marquis G; Joly J; Attye A
    Mycoses; 1993; 36(1-2):35-41. PubMed ID: 8316260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.